Edward M Schaeffer

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi request reprint Amyloidosis of the seminal vesicle and hematospermia
    Edward M Schaeffer
    Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    J Urol 171:2382. 2004
  2. doi request reprint Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Urol Oncol 31:589-94. 2013
  3. doi request reprint Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 73:1673-80. 2013
  4. pmc Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA
    BJU Int 112:751-7. 2013
  5. pmc Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare
    Stacy Loeb
    Department of Urology, New York University, New York, New York 10016, USA
    J Urol 189:867-70. 2013
  6. pmc A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 185:1691-7. 2011
  7. pmc Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 110:1122-8. 2012
  8. pmc Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men
    Debasish Sundi
    The Brady Institute of Urology, The Johns Hopkins Medical Institutions, Baltimore, Maryland
    J Urol 191:60-7. 2014
  9. pmc Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 112:45-53. 2013
  10. pmc African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Debasish Sundi
    Johns Hopkins University, Baltimore, MD, USA
    J Clin Oncol 31:2991-7. 2013

Detail Information

Publications60

  1. ncbi request reprint Amyloidosis of the seminal vesicle and hematospermia
    Edward M Schaeffer
    Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    J Urol 171:2382. 2004
  2. doi request reprint Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21224, USA
    Urol Oncol 31:589-94. 2013
    ..We examine biopsy characteristics of men with high-grade PC at RP to better select those who may benefit from surgery...
  3. doi request reprint Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
    Prostate 73:1673-80. 2013
    ..We report the 30-year institutional experience of radical prostatectomy (RP) for men with clinically localized prostate cancer (PC) found to have lymph node (LN) metastases at surgery...
  4. pmc Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA
    BJU Int 112:751-7. 2013
    ....
  5. pmc Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare
    Stacy Loeb
    Department of Urology, New York University, New York, New York 10016, USA
    J Urol 189:867-70. 2013
    ..We determined whether repeat biopsies are associated with an increased risk of hospitalization compared to the initial biopsy...
  6. pmc A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 185:1691-7. 2011
    ..We investigated outcomes in men with pT3b disease in the contemporary era...
  7. pmc Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 110:1122-8. 2012
    ....
  8. pmc Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men
    Debasish Sundi
    The Brady Institute of Urology, The Johns Hopkins Medical Institutions, Baltimore, Maryland
    J Urol 191:60-7. 2014
    ..We studied radical prostatectomy specimens from black and white men at very low risk to determine whether there are systematic pathological differences...
  9. pmc Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience
    Phillip M Pierorazio
    The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 112:45-53. 2013
    ..Specifically, it addresses approach-specific morbidities and indicates that MIRP is associated with higher rates of 'off-pathway' discharge, most often due to ileus...
  10. pmc African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
    Debasish Sundi
    Johns Hopkins University, Baltimore, MD, USA
    J Clin Oncol 31:2991-7. 2013
    ..To explore whether race-based health disparities exist among men with very low-risk PCa, we evaluated oncologic outcomes of AA men with very low-risk PCa who were candidates for AS but elected to undergo radical prostatectomy (RP)...
  11. pmc Wnt signaling though beta-catenin is required for prostate lineage specification
    Brian W Simons
    Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Dev Biol 371:246-55. 2012
    ..Deletion of beta-catenin in the adult prostate did not significantly affect organ homeostasis. Collectively, these data establish that beta-catenin and Wnt signaling play key roles in prostate lineage specification and bud outgrowth...
  12. doi request reprint Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer
    Ashley E Ross
    James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins Medicinal Institutions, Baltimore, MD, USA
    BJU Int 110:651-7. 2012
    ....
  13. pmc Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
    Paula J Hurley
    Department of Urology, The Johns Hopkins University, Baltimore, MD 21231, USA
    Proc Natl Acad Sci U S A 109:14977-82. 2012
    ..Thus, SPARCL1 is a potent regulator of cell migration/invasion and its loss is independently associated with prostate cancer recurrence...
  14. pmc Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature
    Farzana A Faisal
    Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA
    BJU Int 114:E120-9. 2014
    ....
  15. pmc Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer
    Paula J Hurley
    Brady Urological Institute, Department of Urology, Johns Hopkins University, Baltimore, Maryland Department of Oncology, Johns Hopkins University, Baltimore, Maryland Sidney Kimmel Comprehensive Cancer Institute, Johns Hopkins University, Baltimore, Maryland
    Clin Cancer Res 22:448-58. 2016
    ..Associations of germline ASPN D polymorphisms with risk of prostate cancer progression to metastatic disease have not been assessed...
  16. pmc Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer
    Phillip M Pierorazio
    Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21287, USA
    BJU Int 109:988-93. 2012
    ....
  17. doi request reprint The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance
    Ting Martin Ma
    The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Eur Urol . 2016
    ..Multiparametric magnetic resonance imaging (mpMRI)/ultrasound fusion biopsy (targeted biopsy or TB) may improve detection of high-grade cancers when compared to systematic biopsy (SB)...
  18. pmc Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
    Darian Andreas
    The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Urol Case Rep 7:64-6. 2016
    ..Here we describe a case in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer. ..
  19. pmc Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy
    Jeffrey J Tosoian
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Eur Urol . 2016
    ..25, 95% confidence interval [CI] 1.33-3.82) and metastasis (HR 3.90, 95% CI 1.46-10.4) in multivariable models...
  20. pmc Sox9 is required for prostate development and prostate cancer initiation
    Zhenhua Huang
    Department of Urology, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Oncotarget 3:651-63. 2012
    ..Due to its essential role in cancer initiation, manipulation of Sox9 targets in at-risk men may prove useful in the chemoprevention of prostate cancer...
  21. pmc Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity
    Ashley E Ross
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    BJU Int 108:447-54. 2011
    ..To evaluate the cytotoxicity of dimeric naphthoquinones (BiQs) in prostate cancer cells. • To assess the interaction of dimeric naphthoquinones with common therapies including radiation and docetaxel...
  22. pmc Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging
    Stacy Loeb
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 182:2646-51. 2009
    ..We examined the relationship between body mass index and prostate specific antigen by age in men without prostate cancer in a longitudinal aging study to determine whether prostate specific antigen must be adjusted for body mass index...
  23. pmc Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging
    Stacy Loeb
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Urology 77:143-7. 2011
    ..35 and >2.0 ng/mL/y have been associated with an increased risk of prostate cancer (CaP) death more than 10 years and 1 year before diagnosis, respectively. It is unknown how frequently PSAVs of this magnitude occur in community men...
  24. pmc A Novel Approach for Performing Bone Marrow Aspiration at the Time of Radical Prostatectomy
    Jeffrey J Tosoian
    The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Urol Case Rep 6:45-6. 2016
    ..We herein describe our experience with this technique. ..
  25. doi request reprint Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery
    Jeffrey J Tosoian
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Eur Urol 69:576-81. 2016
    ..It remains unclear whether men selecting active surveillance (AS) are at increased risk of unfavorable longer term outcomes as compared with men who undergo immediate treatment...
  26. doi request reprint Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy
    Stacy Loeb
    Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 184:157-61. 2010
    ..This information would be useful in determining when to initiate androgen deprivation therapy...
  27. pmc Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen
    Phillip M Pierorazio
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 76:715-21. 2010
    ..To evaluate the long-term outcomes of patients with high Gleason sum 8-10 at radical prostatectomy (RP) and to identify the predictors of prostate cancer-specific survival (CSS) in this cohort...
  28. pmc A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression
    Brian W Simons
    The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Pathol 235:478-89. 2015
    ..This study provides direct evidence that prostate inflammation accelerates prostate cancer progression and gives insight into the microenvironment changes induced by inflammation that may accelerate tumour initiation or progression...
  29. doi request reprint Instrument Life for Robot-assisted Laparoscopic Radical Prostatectomy and Partial Nephrectomy: Are Ten Lives for Most Instruments Justified?
    Wesley W Ludwig
    Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Md Electronic address
    Urology 86:942-5. 2015
    ..The majority of robotic instruments have a predetermined lifespan of 10 uses; however, it is unknown if instruments are routinely exchanged before 10 uses in clinical practice...
  30. doi request reprint Gene expression pathways of high grade localized prostate cancer
    Ashley E Ross
    Department of Urology, School of Medicine, Johns Hopkins University, Baltimore, Maryland
    Prostate 71:1568-77. 2011
    ..Here we identify the genes and cellular pathways that distinguish high grade from low grade pathologically localized prostate cancer...
  31. doi request reprint Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
    Jeffrey J Tosoian
    The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 600 N Wolfe Street, Marburg 134, Baltimore, MD 21287, USA
    Nat Rev Urol . 2016
    ..Thus, a protocol for clinicians to manage the patient presenting with oligometastatic prostate cancer would be a useful clinical tool...
  32. pmc HES6 promotes prostate cancer aggressiveness independently of Notch signalling
    Filipe L F Carvalho
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Cell Mol Med 19:1624-36. 2015
    ..Our results did not reveal any cell-autonomous roles for canonical Notch signalling in prostate cancer. However, the results do implicate HES6 as a promoter of prostate cancer progression. ..
  33. pmc Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression
    Paula J Hurley
    The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins University, Baltimore, Maryland The Department of Oncology, Johns Hopkins University, Baltimore, Maryland The Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland
    Cancer Res 75:4322-34. 2015
    ....
  34. doi request reprint Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men
    Zeyad R Schwen
    The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Md Electronic address
    Urology 90:136-40. 2016
    ..To evaluate the association between the Prostate Health Index (PHI) and adverse pathology in a cohort of African American (AA) men undergoing radical prostatectomy...
  35. doi request reprint Complications after prostate biopsy: data from SEER-Medicare
    Stacy Loeb
    Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    J Urol 186:1830-4. 2011
    ..We determined the risk of serious complications requiring hospitalization. We hypothesized that with emerging multidrug resistant organisms there may be an increasing risk of infectious complications...
  36. pmc Bone mineral content and prostate cancer risk: data from the Baltimore Longitudinal Study of Aging
    Stacy Loeb
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, and the National Institute on Ageing, National Institutes of Health Clinical Research Branch, Baltimore, MD, USA
    BJU Int 106:28-31. 2010
    ..Aetiology (inception cohort) Level of Evidence 2b...
  37. ncbi request reprint Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy
    Seyed Saeid Dianat
    The Russell H Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA
    Can J Urol 22:7965-72. 2015
    ....
  38. pmc Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites
    Karen S Sfanos
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
    Cancer Prev Res (Phila) 8:683-92. 2015
    ..These results suggest that bacterial infections and dietary carcinogens, two conceivably preventable cancer risk factors, may synergistically promote tumorigenesis...
  39. doi request reprint A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 61:664-75. 2012
    ..Numerous series have reported cancer control and quality-of-life (QoL) outcomes following treatment with radical prostatectomy (RP)...
  40. doi request reprint Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
    Ashley E Ross
    James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, MD, USA Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA Department of Oncology, Johns Hopkins Hospital, Baltimore, MD, USA
    Eur Urol 69:157-65. 2016
    ..It has been shown that the Decipher test predicts metastatic progression in cohorts that received adjuvant and salvage therapy following RP...
  41. pmc Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
    Nishant Gandhi
    Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer Biol Ther 14:347-56. 2013
    ..0001). Our data suggest that combined RT-AUY922 therapy exhibits promising activity against prostate cancer cells, which should be investigated in clinical studies...
  42. doi request reprint Molecular effects of genistein on male urethral development
    Ashley E Ross
    Department of Urology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    J Urol 185:1894-8. 2011
    ..We investigated the effects of genistein, the primary phytoestrogen in soy, on the molecular program of male urethral development...
  43. pmc What are the outcomes of radical prostatectomy for high-risk prostate cancer?
    Stacy Loeb
    Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    Urology 76:710-4. 2010
    ..These patients are often treated with combined radiation and androgen deprivation therapy, and less is known about the long-term survival in this population after radical prostatectomy (RP)...
  44. doi request reprint Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy
    Edward M Schaeffer
    The James Buchanan Brady Urologic Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    BJU Int 106:62-5. 2010
    ..Aetiology (case series) Level of Evidence 4...
  45. ncbi request reprint Laparoscopic retroperitoneal lymph node dissection: duplication of open technique
    Mohamad E Allaf
    Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland 21237, USA
    Urology 65:575-7. 2005
    ..A modified template dissection that fully duplicates the open technique is now routinely performed at our institution. We describe and show in the accompanying video segments a laparoscopic modified template dissection...
  46. ncbi request reprint Duplex ultrasonography detects clinically significant anomalies of penile arterial vasculature affecting surgical approach to penile straightening
    Edward M Schaeffer
    Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Urology 67:166-9. 2006
    ..To determine the frequency of aberrant penile arterial anatomy in men with Peyronie's disease (PD) and the potential impact on the surgical approach to penile straightening...
  47. ncbi request reprint Prophylactic use of antimicrobials in commonly performed outpatient urologic procedures
    Edward M Schaeffer
    James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21287 2101, USA
    Nat Clin Pract Urol 3:24-31. 2006
    ..Special consideration for the type and duration of prophylaxis should be given to patients with moderate to severe cardiac valvular conditions and recently inserted prosthetic joints...
  48. ncbi request reprint Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation
    Christopher A Warlick
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 67:918-22. 2006
    ....
  49. ncbi request reprint Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma
    Michael Muntener
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21287 2101, USA
    Eur Urol 51:1639-44. 2007
    ..To assess the long-term oncologic efficacy of laparoscopic radical nephroureterectomy (RNU)...
  50. ncbi request reprint Oncologic outcomes of extravesical stapling of distal ureter in laparoscopic nephroureterectomy
    Frederico R Romero
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Endourol 21:1025-7. 2007
    ..To evaluate the safety and oncologic efficacy of extravesical laparoscopic stapling of the distal ureter and bladder cuff during nephroureterectomy for pelvicaliceal transitional-cell carcinoma (TCC)...
  51. doi request reprint Laparoscopic radical nephroureterectomy with en-bloc distal ureteral and bladder cuff excision using a single position pneumovesicum method
    Thomas J Guzzo
    The James Buchanan Brady Urologic Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 72:850-2. 2008
    ..This technique is efficient, technically feasible and adheres to the oncologic principles of radical nephroureterectomy...
  52. ncbi request reprint Urinary markers in the detection of bladder cancer: what's new?
    Matthew E Nielsen
    Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 2101, USA
    Curr Opin Urol 16:350-5. 2006
    ..In the context of relative limitations of the current standard of cystoscopy and cytology, there has been burgeoning activity in the development of novel molecular urine-based markers for bladder cancer detection...
  53. doi request reprint Cystoscopic management of an extruded coil from arteriovenous fistula embolization using arthroscopic instruments
    Edward M Schaeffer
    Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Endourol 22:1527-9. 2008
    ..We describe one potential complication of transcatheter embolization that involves necrosis of the bladder wall with a novel technique for endoscopic management of an extruded coil in the bladder...
  54. ncbi request reprint Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer
    Matthew E Nielsen
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    Urology 70:1168-72. 2007
    ..LRPLND is emerging as a less-invasive alternative in the adjuvant surgical treatment of patients with testicular cancer...
  55. ncbi request reprint Rebuttal from authors re: Peter Albers. Quality criteria of laparoscopic nephroureterectomy. Eur Urol. 2007;51:1481-2
    Michael Muntener
    Eur Urol 51:1482-4. 2007
  56. ncbi request reprint Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy
    Michael Muntener
    The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 2101, USA
    Urology 70:864-8. 2007
    ..To address the incidence of local recurrence and port site metastasis in patients who underwent laparoscopic radical nephroureterectomy (RNU) for upper tract transitional cell carcinoma (TCC)...
  57. ncbi request reprint Pyeloduodenal fistula due to advanced upper tract malignancy
    David J Hernandez
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Urology 69:1206-7. 2007
  58. doi request reprint Intraperitoneal effects of extraperitoneal laparoscopic radical prostatectomy
    Trinity J Bivalacqua
    The Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21224, USA
    Urology 72:273-7. 2008
    ..To compare routine radiologic and laboratory findings after extraperitoneal and transperitoneal laparoscopic radical prostatectomy (eLRP, tLRP) and assess relevant clinical correlations...
  59. ncbi request reprint Adrenal myelolipoma
    Edward M Schaeffer
    Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA
    J Urol 173:1760. 2005
  60. ncbi request reprint Urological radiographic manifestations of the Ehlers-Danlos syndrome
    Jonathan Berger
    Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Urol 178:1490. 2007